In ₹ Crore except Per Share Latest Annual	CFEL FY24	ASIANTNE FY25	BNAGROCHEM FY25	CRAVATEX FY22	Peer Average
Valuation — at last close
P/E	33.01×	99.78×	—	◆ 19.05×	59.41× -44%
P/B	0.61×	◆ 0.33×	—	1.98×	1.16× -47%
EV/EBITDA	◆ -1039.92×	87.99×	—	-29.48×	29.25× -3655%
Market Cap	₹84.5 Cr	₹17.8 Cr	—	₹83.6 Cr	₹50.7 Cr +67%
Profitability
EBITDA Margin	-1.69%	◆ 0.69%	-12.51%	-120.33%	-44.05% +96%
Net Income Margin	50.62%	0.35%	6.60%	◆ 179.59%	62.18% -19%
Return on Common Equity	1.85%	0.36%	10.34%	◆ 10.41%	7.04% -74%
Return on Capital Employed	-0.16%	◆ 0.62%	-17.55%	-5.82%	-7.58% +98%
Return on Assets	1.77%	0.26%	◆ 8.89%	8.15%	5.77% -69%
Credit & Quality
Total Debt/Equity	◆ 0.03×	0.24×	0.14×	0.10×	0.16× -81%
Interest Coverage	-3.05×	◆ 0.19×	-4.31×	-4.08×	-2.73× -12%
Scale — latest FY
Revenue / Total Income	₹5.1 Cr	₹50.9 Cr	₹299 Cr	₹2.4 Cr	₹118 Cr -96%
Net Income	₹2.6 Cr	₹0.2 Cr	₹19.8 Cr	₹4.4 Cr	₹8.1 Cr -68%
Total Assets	₹144 Cr	₹71.7 Cr	₹372 Cr	₹53.9 Cr	₹166 Cr -13%
EPS	₹1.02	₹0.09	—	₹16.98	₹8.54 -88%
Book Value per Share	₹55.22	₹27.18	—	₹163.17	₹95.18 -42%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY24 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.